with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you – we hate SPAM too.

09 Aug,2022

ARMI Alumni in Industry: Celia Vandestadt

From being a full-time myotherapist to undertaking neuroregeneration research at ARMI with the Kaslin Group and then joining the world of data consulting after completing her PhD, ARMI alumni Celia Vandestadt’s career journey has been unconventional and unique. Today, Celia is a data consultant at Eliiza, a Melbourne-based consultancy that applies Artificial Intelligence (AI) and […]

04 Aug,2022

ARMI Alumni in Industry: Harriet Manley

Postgraduate studies at ARMI can open up a number of potential career pathways. With the Institute’s strong focus on deepening ties with both the local and global biotechnology industry, it is no surprise that we find ARMI alumni scattered across the world, working in organisations and companies that vary in size, research field, and role […]

21 Jul,2022

Rishika Turaga: ARMI’s Newest Social Media Ambassador

ARMI’s Master’s student Rishika Turaga is the newest recruit of the Institute’s Social Media Ambassador Program. As an Ambassador, Rishika will be mentored in using social media professionally and in science communications. “I think connectivity and sharing knowledge in science and social media’s role are critical,” commented Rishika. “If you want to talk to researchers, […]

20 Jul,2022

Monash biotech start-up receives funding for muscular dystrophies

A new Monash biotech company has received funding to develop novel therapies for treatment of muscular dystrophies.  Myostellar, established by researchers from Monash’s Australian Regenerative Medicine Institute (ARMI), has been awarded a $500,000 grant from CUREator, a national biomedical incubator managed by life science collaboration Brandon BioCatalyst. Professor Peter Currie, who is leading the project alongside […]

19 May,2022

New Grant to Galvanise ARMI and AstraZeneca Collaboration to boost macrophage-based technologies for tissue regeneration

A three-year grant from the Australian Research Council will help strengthen the partnership between Australian Regenerative Medicine Institute (ARMI) and AstraZeneca. The $AUD857,800 grant will enable critical research into developing macrophage-based technologies for tissue regeneration to be conducted by a multidisciplinary team led by Professor Peter Currie and Associate Professor Mikaël Martino at ARMI and […]

11 May,2022

Regen Med Researcher Recognised by Victorian Premier’s Awards

Dr Xiaodong (Ethan) Liu, a regenerative medicine researcher, based at the Monash Biomedicine Discovery Institute (BDI) and Australian Regenerative Medicine Institute (ARMI), was announced a winner at the Victorian Premier’s Awards for Health and Medical Research in a ceremony on 4 April 2022 at Deakin Edge. Xiaodong was also named the winner of the Basic […]

09 May,2022

Putting the Medicine in Regenerative Medicine

The translation and commercialisation of medicines and technologies is a long and complex process that can cost billions of dollars. While these advances have the potential to disrupt industries and improve the quality of life for patients, only a small fraction of these ever “escape” the laboratory and fulfil their potential. Identifying market applications in […]

30 Mar,2022

Interview with Professor Alan Trounson, CEO of Cartherics

Cartherics’ partnership with ARMI and CCRM Australia is another step towards synergy between industry and academia in Australia’s biotechnology sector. CEO of Cartherics, Professor Alan Trounson AO, shares his views on the collaboration, translating medical research in Australia and the future of regenerative medicine. Q: What value does this partnership between ARMI, Cartherics and CCRM […]

21 Mar,2022

The Diversification of ARMI’s Industry Advisory Committee

The ability to unlimitedly self-renew and develop into numerous cell types has made regenerative medicine a growing discipline of medical research. A strength of ARMI’s research program is the diversity of topic areas, ranging from organ engineering and synthetic biology to immunity and regeneration, all of which have commercial promise. In addition to cell-based therapies […]

28 Feb,2022

Dr. Meroula Richardson: From childhood on a farm to a leading cardiologist to ARMILAB

As a cardiologist, regenerative medicine holds enormous appeal for Dr. Meroula Richardson. “Transplantation and heart failure therapies are great – but they are treatment, not a cure,” said Meroula. “The potential for molecular and cell-based therapy to provide a cure is both real and exciting.” That is part of why Meroula has joined ARMI’s Leadership […]